Panama - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPanama: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024
Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Panama
The Panamanian prophylactic medicaments containing insulin market rose to $X in 2022, increasing by X% against the previous year. In general, consumption saw buoyant growth. Over the period under review, the market reached the maximum level at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.
Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Panama
In value terms, prophylactic medicaments containing insulin production rose to $X in 2022 estimated in export price. Over the period under review, production continues to indicate a buoyant expansion. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, production reached the maximum level at $X in 2020; afterwards, it flattened through to 2022.
Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Exports from Panama
In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses decreased by X% to X tons, falling for the second year in a row after three years of growth. Over the period under review, exports showed a abrupt slump. The most prominent rate of growth was recorded in 2020 with an increase of X%. Over the period under review, the exports hit record highs at X tons in 2014; however, from 2015 to 2022, the exports remained at a lower figure.
In value terms, prophylactic medicaments containing insulin exports totaled $X in 2022. Overall, exports recorded a slight expansion. The most prominent rate of growth was recorded in 2018 with an increase of X%. Over the period under review, the exports reached the peak figure at $X in 2020; however, from 2021 to 2022, the exports remained at a lower figure.
Exports by Country
Honduras (X tons), Guatemala (X tons) and the Dominican Republic (X tons) were the main destinations of prophylactic medicaments containing insulin exports from Panama, together comprising X% of total exports. El Salvador, Nicaragua, Costa Rica, Jamaica and Trinidad and Tobago lagged somewhat behind, together comprising a further X%.
From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Nicaragua (with a CAGR of X%), while the other leaders experienced mixed trend patterns.
In value terms, Honduras ($X), Guatemala ($X) and the Dominican Republic ($X) were the largest markets for prophylactic medicaments containing insulin exported from Panama worldwide, with a combined X% share of total exports. El Salvador, Nicaragua, Costa Rica, Jamaica and Trinidad and Tobago lagged somewhat behind, together comprising a further X%.
Among the main countries of destination, Nicaragua, with a CAGR of X%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, stabilizing at the previous year. Over the period under review, the export price continues to indicate resilient growth. The pace of growth appeared the most rapid in 2018 an increase of X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2019 to 2022, the average export prices remained at a somewhat lower figure.
Average prices varied noticeably for the major external markets. In 2022, amid the top suppliers, the highest price was recorded for prices to Jamaica ($X per ton) and El Salvador ($X per ton), while the average price for exports to the Dominican Republic ($X per ton) and Trinidad and Tobago ($X per ton) were amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Jamaica (X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Imports into Panama
Prophylactic medicaments containing insulin imports into Panama dropped to X tons in 2022, which is down by X% compared with the previous year's figure. Over the period under review, imports saw a deep setback. The pace of growth was the most pronounced in 2016 when imports increased by X%. Imports peaked at X tons in 2014; however, from 2015 to 2022, imports remained at a lower figure.
In value terms, prophylactic medicaments containing insulin imports surged to $X in 2022. In general, imports continue to indicate a deep slump. The most prominent rate of growth was recorded in 2019 with an increase of X%. Over the period under review, imports hit record highs at $X in 2014; however, from 2015 to 2022, imports stood at a somewhat lower figure.
Imports by Country
In 2022, Denmark (X tons) constituted the largest prophylactic medicaments containing insulin supplier to Panama, with a X% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Denmark exceeded the figures recorded by the second-largest supplier, Free Zones (X tons), twofold.
From 2012 to 2022, the average annual growth rate of volume from Denmark amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Free Zones (X% per year) and France (X% per year).
In value terms, Free Zones ($X), Denmark ($X) and France ($X) were the largest prophylactic medicaments containing insulin suppliers to Panama, together comprising X% of total imports.
Free Zones, with a CAGR of X%, saw the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced mixed trend patterns.
Import Prices by Country
In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, growing by X% against the previous year. Overall, import price indicated a perceptible increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price increased by X% against 2018 indices. The most prominent rate of growth was recorded in 2019 an increase of X% against the previous year. Over the period under review, average import prices reached the maximum at $X per ton in 2015; however, from 2016 to 2022, import prices failed to regain momentum.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Free Zones ($X per ton), while the price for Denmark ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Free Zones (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Panama. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
- Panama
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Panama
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU.
This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.
- Price for Prophylactic Medicaments Containing Insulin Panama
- Prophylactic Medicaments Containing Insulin Market
- Hormones Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Sterile Medical Adhesion Barrier Market
- Human and Animal Blood Market